251 related articles for article (PubMed ID: 7586678)
1. The restricted IgG1 antibody response to maedi visna virus is seen following infection but not following immunization with recombinant gag protein.
Bird P; Reyburn HT; Blacklaws BA; Allen D; Nettleton P; Yirrell DL; Watt N; Sargan D; McConnell I
Clin Exp Immunol; 1995 Nov; 102(2):274-80. PubMed ID: 7586678
[TBL] [Abstract][Full Text] [Related]
2. Immune response to individual maedi-visna virus gag antigens.
Singh I; McConnell I; Blacklaws B
J Virol; 2006 Jan; 80(2):912-9. PubMed ID: 16378993
[TBL] [Abstract][Full Text] [Related]
3. Serum containing ovine IgG2 antibody specific for maedi visna virus envelope glycoprotein mediates antibody dependent cellular cytotoxicity.
Singh I; McConnell I; Dalziel R; Blacklaws BA
Vet Immunol Immunopathol; 2006 Oct; 113(3-4):357-66. PubMed ID: 16876878
[TBL] [Abstract][Full Text] [Related]
4. Maedi-visna virus and its relationship to human immunodeficiency virus.
Thormar H
AIDS Rev; 2005; 7(4):233-45. PubMed ID: 16425963
[TBL] [Abstract][Full Text] [Related]
5. Comparison of a maedi-visna virus CA-TM fusion protein ELISA with other assays for detecting sheep infected with North American ovine lentivirus strains.
DeMartini JC; Halsey W; Boshoff C; York D; Howell MD
Vet Immunol Immunopathol; 1999 Oct; 71(1):29-40. PubMed ID: 10522784
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of sheep with Maedi-visna virus gag gene and protein, beneficial or harmful?
Torsteinsdóttir S; Carlsdóttir HM; Svansson V; Matthíasdóttir S; Martin AH; Pétursson G
Vaccine; 2007 Sep; 25(37-38):6713-20. PubMed ID: 17686553
[TBL] [Abstract][Full Text] [Related]
7. Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue.
Bird P; Blacklaws B; Reyburn HT; Allen D; Hopkins J; Sargan D; McConnell I
J Virol; 1993 Sep; 67(9):5187-97. PubMed ID: 8394444
[TBL] [Abstract][Full Text] [Related]
8. Mucosal immunization of sheep with a Maedi-Visna virus (MVV) env DNA vaccine protects against early MVV productive infection.
González B; Reina R; García I; Andrés S; Glaria I; Alzueta M; Mora MI; Jugo BM; Arrieta-Aguirre I; de la Lastra JM; Rodríguez D; Rodríguez JR; Esteban M; Grilló MJ; Blacklaws BA; Harkiss GD; Chebloune Y; Luján L; de Andrés D; Amorena B
Vaccine; 2005 Jul; 23(34):4342-52. PubMed ID: 16005743
[TBL] [Abstract][Full Text] [Related]
9. Antibody response in sheep experimentally infected with different small ruminant lentivirus genotypes.
Lacerenza D; Giammarioli M; Grego E; Marini C; Profiti M; Rutili D; Rosati S
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):264-71. PubMed ID: 16698088
[TBL] [Abstract][Full Text] [Related]
10. Detection of Maedi-Visna virus antibodies using a single fusion transmembrane-core p25 recombinant protein ELISA and a modified receiver-operating characteristic analysis to determine cut-off values.
Boshoff CH; Dungu B; Williams R; Vorster J; Conradie JD; Verwoerd DW; York DF
J Virol Methods; 1997 Jan; 63(1-2):47-56. PubMed ID: 9015275
[TBL] [Abstract][Full Text] [Related]
11. Mimicry of a 21.5 kDa myelin basic protein peptide by a Maedi Visna virus polymerase peptide does not contribute to the pathogenesis of encephalitis in sheep.
Davies JM; Watt NJ; Torsteinsdottir S; Carnegie PR
Vet Immunol Immunopathol; 1996 Dec; 55(1-3):127-39. PubMed ID: 9014312
[TBL] [Abstract][Full Text] [Related]
12. Immune response to maedi-visna virus.
Torsteinsdottir S; Andresdottir V; Arnarson H; Petursson G
Front Biosci; 2007 Jan; 12():1532-43. PubMed ID: 17127400
[TBL] [Abstract][Full Text] [Related]
13. Maedi-visna virus infection in sheep: a review.
Pépin M; Vitu C; Russo P; Mornex JF; Peterhans E
Vet Res; 1998; 29(3-4):341-67. PubMed ID: 9689746
[TBL] [Abstract][Full Text] [Related]
14. Mapping and characterization of visna/maedi virus cytotoxic T-lymphocyte epitopes.
Wu C; Barbezange C; McConnell I; Blacklaws BA
J Gen Virol; 2008 Oct; 89(Pt 10):2586-2596. PubMed ID: 18796728
[TBL] [Abstract][Full Text] [Related]
15. Mucosal vaccination with an attenuated maedi-visna virus clone.
Pétursson G; Matthíasdóttir S; Svansson V; Andrésdóttir V; Georgsson G; Martin AH; Agnarsdóttir G; Gísladóttir E; Arnadóttir S; Högnadóttir S; Jónsson SR; Andrésson OS; Torsteinsdóttir S
Vaccine; 2005 May; 23(24):3223-8. PubMed ID: 15837223
[TBL] [Abstract][Full Text] [Related]
16. Human and ovine lentiviral infections compared.
Pétursson G; Andrésdóttir V; Andrésson O; Torsteinsdóttir S; Georgsson G; Pálsson PA
Comp Immunol Microbiol Infect Dis; 1991; 14(4):277-87. PubMed ID: 1684142
[TBL] [Abstract][Full Text] [Related]
17. Identification and subcellular localization of the Q gene product of visna virus.
Audoly G; Sauze N; Harkiss G; Vitu C; Russo P; Querat G; Suzan M; Vigne R
Virology; 1992 Aug; 189(2):734-9. PubMed ID: 1322597
[TBL] [Abstract][Full Text] [Related]
18. CD4(+) T-cells are required for the establishment of maedi-visna virus infection in macrophages but not dendritic cells in vivo.
Eriksson K; McInnes E; Ryan S; Tonks P; McConnell I; Blacklaws B
Virology; 1999 Jun; 258(2):355-64. PubMed ID: 10366572
[TBL] [Abstract][Full Text] [Related]
19. The origin of lentivirus research: Maedi-visna virus.
Thormar H
Curr HIV Res; 2013 Jan; 11(1):2-9. PubMed ID: 23278353
[TBL] [Abstract][Full Text] [Related]
20. Early pulmonary cell response during experimental maedi-visna virus infection.
Begara I; Luján L; Collie DD; Miller HR; Watt NJ
Vet Immunol Immunopathol; 1996 Dec; 55(1-3):115-26. PubMed ID: 9014311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
